Outcomes Associated With Use of a Kinin B2 Receptor Antagonist Among Patients With COVID-19

This case-control study examines the association between receipt of the bradykinin 2 (B2) receptor antagonist icatibant and improved oxygenation in patients with coronavirus disease 2019 (COVID-19).

Na minha lista:
Bibliografiske detaljer
Udgivet i:JAMA Netw Open
Main Authors: van de Veerdonk, Frank L., Kouijzer, Ilse J. E., de Nooijer, Aline H., van der Hoeven, Hans G., Maas, Coen, Netea, Mihai G., Brüggemann, Roger J. M.
Format: Artigo
Sprog:Inglês
Udgivet: American Medical Association 2020
Fag:
Research Letter
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7426743/
https://ncbi.nlm.nih.gov/pubmed/32789513
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamanetworkopen.2020.17708
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker